容积分期立体定向放射外科治疗颅内动静脉畸形:基于18年经验的结果
回顾性分析34例接受容积分期立体定向放射外科(VS-SRS)的颅内动静脉畸形(AVM)患者,中位随访8.2年。18例(53%)达到畸形血管团闭塞,3年、5年、7年闭塞率分别为14%、54%、75%。6例(18%)发生11次出血,2例(6%)出现永久性放射副反应。作者认为VS-SRS治疗大容积AVM的放射副反应率低,需进一步研究剂量递增和减少单次治疗体积以提高闭塞率。
要点
- VS-SRS治疗后18例(53%)达到AVM闭塞,7年闭塞率为75%。
- 6例(18%)发生11次出血,7年首次出血 actuarial 风险为19%。
- 2例(6%)出现永久性放射副反应,作者认为VS-SRS治疗大容积AVM的放射副反应率低。
核心结论
- VS-SRS使大容积颅内AVM得以治疗,且放射副反应率低。
- 需进一步研究剂量递增和减少单次治疗体积,以确定能否提高该技术的闭塞率。
研究设计与样本
- 回顾性研究,纳入1997年至2012年间接受VS-SRS的34例AVM患者。
- 中位分期数为2期(范围2-4),治疗中位AVM体积22.2 cm³(范围7.4-56.7)。
- 中位AVM边缘剂量16 Gy(范围14-18),中位放射外科AVM评分2.81(范围1.54-6.45)。
- VS-SRS后中位随访8.2年(范围3-13.3)。
主要发现
- 18例(53%)在VS-SRS后达到畸形血管团闭塞;闭塞率3年为14%、5年为54%、7年为75%。
- 6例(18%)在VS-SRS后发生11次出血;其中2例(6%)神经功能稳定,2例(6%)有明显缺损,2例(6%)死亡。
- VS-SRS后首次出血的 actuarial 风险1年为6%、3年为12%、7年为19%。
- 6例(18%)接受重复SRS,均达到畸形血管团闭塞,总体治愈率为71%。
- 2例(6%)在VS-SRS或重复SRS后出现永久性放射副反应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation-based treatment options of large intracranial arteriovenous malformations (AVM) must balance the likelihood of obliteration with the risk of adverse radiation effects (ARE). OBJECTIVE: To analyze the efficacy and risks of volume-staged stereotactic radiosurgery (VS-SRS) for AVM. METHODS: Retrospective study of 34 AVM patients having VS-SRS between 1997 and 2012. A median of 2 stages (range, 2-4) was used to treat a median AVM volume of 22.2 cm 3 (range, 7.4-56.7). The median AVM margin dose was 16 Gy (range, 14-18); the median radiosurgery-based AVM score was 2.81 (range, 1.54-6.45). The median follow-up after VS-SRS was 8.2 years (range, 3-13.3). RESULTS: Nidus obliteration was noted in 18 patients (53%) after VS-SRS. The rate of obliteration was 14% at 3 years, 54% at 5 years, and 75% at 7 years. Six patients (18%) had 11 bleeds after VS-SRS. Two patients (6%) remained neurologically stable, 2 (6%) patients had significant deficits, and 2 patients (6%) died. The actuarial risk of a first bleed after VS-SRS was 6% at 1 year, 12% at 3 years, and 19% at 7 years. Six patients (18%) underwent repeat SRS; all achieved nidus obliteration for an overall cure rate of 71%. Two patients (6%) had a permanent ARE after VS-SRS or repeat SRS. CONCLUSION: VS-SRS permitted large volume intracranial AVM to be treated with a low rate of ARE. Further study is needed on dose escalation and decreasing the treatment volume per stage to determine if this will increase the rate of obliteration with this technique.
引用
- Pollock BE, Link MJ, Stafford SL, et al. Volume-Staged Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations: Outcomes Based on an 18-Year Experience. Neurosurgery. 2017. PMID: 28362923. doi:10.1093/neuros/nyw107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。